NEWS

April 30, 2013

Raptor Pharmaceutical’s PROCYSBI™ Receives FDA Approval for the Treatment of Nephropathic Cystinosis

April 29, 2013

Clarke Futch to Speak on BioWorld Webinar

February 26, 2013

TearScience® Secures up to $70 Million in Funding from Healthcare Royalty Partners

January 4, 2013

HC Royalty Expands Strategic Advisory Board

January 3, 2013

HC Royalty Commits Over $425 Million in 2012

December 20, 2012

Raptor lines up $50 million loan ahead of decision date on rare disease drug

December 20, 2012

HC Royalty Invests $50 Million in PROCYSBI™

July 2, 2012

Healthcare reform doles out opps for PE, more consolidation

June 25, 2012

Cowen Royalty Announces Name Change, Unveils New Website

June 7, 2012

Medigene Monetizes Eligard® Royalty for USD 17.68 Million